Document Detail

A Clinical Trial Testing the Safety and Efficacy of a Standardized Eucommia ulmoides Oliver Bark Extract to Treat Hypertension.
MedLine Citation:
PMID:  22214253     Owner:  NLM     Status:  In-Data-Review    
BACKGROUND: A tea made from Eucommia ulmoides leaves and bark is part of the Japanese diet. Eucommia is an herbal medicine that, by increasing nitric oxide, reduced blood pressure (BP) in rats and humans in an uncontrolled clinical trial.
OBJECTIVE: A controlled clinical trial was conducted to evaluate an aqueous bark extract of Eucommia standardized to eight percent pinoresinol di-beta-D-glucoside (PG) for BP reduction in humans.
METHODS: Study 1: Twenty-four healthy adult subjects with a BP between 120-160/80-100 mmHg were randomized to Eucommia extract 500 mg three times daily for eight weeks. Automatic 24-hour ambulatory blood pressure monitoring (24-h ABPM) was utilized at baseline and after eight weeks. Study 2: The effect of the Eucommia extract on isoproterenol-stimulated lipolysis was evaluated in a human fat cell assay to determine whether Eucommia was a beta-adrenergic blocker. Study 3: Thirty healthy adult subjects with a BP between 120-160/80-100 mmHg were randomized to 1 g Eucommia extract three times daily for two weeks with 24-h ABPM at baseline and after two weeks.
RESULTS: Study 1: There was no toxicity or any difference in BP between the two groups. Study 2: Eucommia at 0.5% w/v reduced isoproterenol-stimulated lipolysis from 2.67 to 1.4 times the buffer control (P<0.001). Study 3: The Eucommia extract was well-tolerated and reduced BP by an average of 7.5/3.9 mmHg (P<0.008).
CONCLUSION: The standardized Eucommia extract reduced BP and has beta-adrenergic blocking activity. Eucommia may be an appropriate nutraceutical intervention for prehypertension.
Frank Greenway; Zhijun Liu; Ying Yu; Alok Gupta
Related Documents :
6795233 - Evaluation of portal hypertension in cases of hepatosplenic schistosomiasis using ultra...
6105683 - Alpha-adrenergic blocking agents and the cardiovascular response to pharmacological dos...
15109933 - Evidence that venoconstriction reverses the phase ii sympathoinhibitory and bradycardic...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Alternative medicine review : a journal of clinical therapeutic     Volume:  16     ISSN:  1089-5159     ISO Abbreviation:  Altern Med Rev     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2012-01-04     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9705340     Medline TA:  Altern Med Rev     Country:  United States    
Other Details:
Languages:  eng     Pagination:  338-47     Citation Subset:  K    
Correspondence address: Pennington Biomedical Research Center, Louisiana State University System, 6400 Perkins Road, Baton Rouge, LA 70808 Email:
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Complementary and alternative medical therapies for children with attention-deficit/hyperactivity di...
Next Document:  The Effects of L-Theanine (Suntheanine®) on Objective Sleep Quality in Boys with Attention Deficit H...